142 related articles for article (PubMed ID: 21789013)
1. Impact of delayed radiotherapy on local control in node-negative breast cancer patients treated with breast-conserving surgery and adjuvant radiotherapy without chemotherapy.
Kim K; Chie EK; Han W; Noh DY; Ha SW
Tumori; 2011; 97(3):341-4. PubMed ID: 21789013
[TBL] [Abstract][Full Text] [Related]
2. Treatment results and prognostic factors of early breast cancer treated with a breast conserving operation and radiotherapy.
Kim KJ; Huh SJ; Yang JH; Park W; Nam SJ; Kim JH; Lee JH; Kang SS; Lee JE; Kang MK; Park YJ; Nam HR
Jpn J Clin Oncol; 2005 Mar; 35(3):126-33. PubMed ID: 15741302
[TBL] [Abstract][Full Text] [Related]
3. Local recurrences and distant metastases after breast-conserving surgery and radiation therapy for early breast cancer.
Touboul E; Buffat L; Belkacémi Y; Lefranc JP; Uzan S; Lhuillier P; Faivre C; Huart J; Lotz JP; Antoine M; Pène F; Blondon J; Izrael V; Laugier A; Schlienger M; Housset M
Int J Radiat Oncol Biol Phys; 1999 Jan; 43(1):25-38. PubMed ID: 9989511
[TBL] [Abstract][Full Text] [Related]
4. Does delay in breast irradiation following conservative breast surgery in node-negative breast cancer patients have an impact on risk of recurrence?
Vujovic O; Perera F; Dar AR; Stitt L; Yu E; Voruganti SM; Truong PT
Int J Radiat Oncol Biol Phys; 1998 Mar; 40(4):869-74. PubMed ID: 9531372
[TBL] [Abstract][Full Text] [Related]
5. Breast-conserving surgery with or without irradiation in women aged 65 years or older with early breast cancer (PRIME II): a randomised controlled trial.
Kunkler IH; Williams LJ; Jack WJ; Cameron DA; Dixon JM;
Lancet Oncol; 2015 Mar; 16(3):266-73. PubMed ID: 25637340
[TBL] [Abstract][Full Text] [Related]
6. Interval between breast-conserving surgery and start of radiation therapy in early-stage breast cancer is not predictive of local recurrence: a single-institution experience.
Barbieri V; Sanpaolo P; Genovesi D
Clin Breast Cancer; 2011 Apr; 11(2):114-20. PubMed ID: 21569997
[TBL] [Abstract][Full Text] [Related]
7. 10 year survival after breast-conserving surgery plus radiotherapy compared with mastectomy in early breast cancer in the Netherlands: a population-based study.
van Maaren MC; de Munck L; de Bock GH; Jobsen JJ; van Dalen T; Linn SC; Poortmans P; Strobbe LJA; Siesling S
Lancet Oncol; 2016 Aug; 17(8):1158-1170. PubMed ID: 27344114
[TBL] [Abstract][Full Text] [Related]
8. Tumor bed boost omission after negative re-excision in breast-conservation treatment.
Arthur DW; Cuttino LW; Neuschatz AC; Koo DT; Morris MM; Bear HD; Kaplan BJ; Dawson K; Wazer DE
Ann Surg Oncol; 2006 Jun; 13(6):794-801. PubMed ID: 16614879
[TBL] [Abstract][Full Text] [Related]
9. Omission of axillary lymph node dissection in early-stage breast cancer: effect on treatment outcome.
Kuznetsova M; Graybill JC; Zusag TW; Hartsell WF; Griem KL
Radiology; 1995 Nov; 197(2):507-10. PubMed ID: 7480703
[TBL] [Abstract][Full Text] [Related]
10. Outcome of radiotherapy after breast conserving surgery in screen detected breast cancers.
Magee B; Stewart AL; Swindell R
Clin Oncol (R Coll Radiol); 1999; 11(1):40-5. PubMed ID: 10194585
[TBL] [Abstract][Full Text] [Related]
11. Does the placement of surgical clips within the excision cavity influence local control for patients treated with breast-conserving surgery and irradiation.
Fein DA; Fowble BL; Hanlon AL; Hoffman JP; Sigurdson ER; Eisenberg BL
Int J Radiat Oncol Biol Phys; 1996 Mar; 34(5):1009-17. PubMed ID: 8600083
[TBL] [Abstract][Full Text] [Related]
12. IOERT as anticipated tumor bed boost during breast-conserving surgery after neoadjuvant chemotherapy in locally advanced breast cancer--results of a case series after 5-year follow-up.
Fastner G; Reitsamer R; Ziegler I; Zehentmayr F; Fussl C; Kopp P; Peintinger F; Greil R; Fischer T; Deutschmann H; Sedlmayer F
Int J Cancer; 2015 Mar; 136(5):1193-201. PubMed ID: 24995409
[TBL] [Abstract][Full Text] [Related]
13. Radiotherapy boost dose-escalation for invasive breast cancer after breast-conserving surgery: 2093 patients treated with a prospective margin-directed policy.
Livi L; Meattini I; Franceschini D; Saieva C; Meacci F; Marrazzo L; Gerlain E; Desideri I; Scotti V; Nori J; Sanchez LJ; Orzalesi L; Bonomo P; Greto D; Bianchi S; Biti G
Radiother Oncol; 2013 Aug; 108(2):273-8. PubMed ID: 23490271
[TBL] [Abstract][Full Text] [Related]
14. Concurrent versus sequential administration of CMF chemotherapy and radiotherapy after breast-conserving surgery in early breast cancer.
Kim K; Chie EK; Han W; Noh DY; Oh DY; Im SA; Kim TY; Bang YJ; Ha SW
Tumori; 2011; 97(3):280-5. PubMed ID: 21789003
[TBL] [Abstract][Full Text] [Related]
15. Medial tumor localization in breast cancer--an unappreciated risk factor?
Bräutigam E; Track C; Seewald DH; Feichtinger J; Spiegl K; Hammer J
Strahlenther Onkol; 2009 Oct; 185(10):663-8. PubMed ID: 19806331
[TBL] [Abstract][Full Text] [Related]
16. Quality of life after breast-conserving therapy and adjuvant radiotherapy for non-low-risk ductal carcinoma in situ (BIG 3-07/TROG 07.01): 2-year results of a randomised, controlled, phase 3 trial.
King MT; Link EK; Whelan TJ; Olivotto IA; Kunkler I; Westenberg AH; Gruber G; Schofield P; Chua BH;
Lancet Oncol; 2020 May; 21(5):685-698. PubMed ID: 32203696
[TBL] [Abstract][Full Text] [Related]
17. Late side-effects and cosmetic results of accelerated partial breast irradiation with interstitial brachytherapy versus whole-breast irradiation after breast-conserving surgery for low-risk invasive and in-situ carcinoma of the female breast: 5-year results of a randomised, controlled, phase 3 trial.
Polgár C; Ott OJ; Hildebrandt G; Kauer-Dorner D; Knauerhase H; Major T; Lyczek J; Guinot JL; Dunst J; Miguelez CG; Slampa P; Allgäuer M; Lössl K; Polat B; Kovács G; Fischedick AR; Fietkau R; Resch A; Kulik A; Arribas L; Niehoff P; Guedea F; Schlamann A; Pötter R; Gall C; Uter W; Strnad V;
Lancet Oncol; 2017 Feb; 18(2):259-268. PubMed ID: 28094198
[TBL] [Abstract][Full Text] [Related]
18. Local recurrence rates in breast cancer patients treated with intraoperative electron-boost radiotherapy versus postoperative external-beam electron-boost irradiation. A sequential intervention study.
Reitsamer R; Peintinger F; Kopp M; Menzel C; Kogelnik HD; Sedlmayer F
Strahlenther Onkol; 2004 Jan; 180(1):38-44. PubMed ID: 14704843
[TBL] [Abstract][Full Text] [Related]
19. Impact of pathological characteristics on local relapse after breast-conserving therapy: a subgroup analysis of the EORTC boost versus no boost trial.
Jones HA; Antonini N; Hart AA; Peterse JL; Horiot JC; Collin F; Poortmans PM; Oei SB; Collette L; Struikmans H; Van den Bogaert WF; Fourquet A; Jager JJ; Schinagl DA; Wárlám-Rodenhuis CC; Bartelink H
J Clin Oncol; 2009 Oct; 27(30):4939-47. PubMed ID: 19720914
[TBL] [Abstract][Full Text] [Related]
20. Surgical margin and breast recurrence after breast-conserving therapy.
Horiguchi J; Iino Y; Takei H; Maemura M; Yokoe T; Niibe H; Yamakawa M; Nakajima T; Oyama T; Morishita Y
Oncol Rep; 1999; 6(1):135-8. PubMed ID: 9864416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
